论文部分内容阅读
乙型肝炎病毒(HBV)感染呈世界性流行,但世界各地流行强度差异较大。据世界卫生组织(WHO)报道,全球约20亿人曾感染过HBV,其中3.5亿人为慢性HBV感染者,每年约有100万人死于HBV感染所致的肝衰竭、肝硬化和原发性肝细胞癌(HHC)[1]。目前,世界上尚无治疗乙型肝炎(乙肝)的特效药,接种乙肝疫苗是预防HBV感染最有效的方法。但接种乙肝
Hepatitis B virus (HBV) infection is a worldwide epidemic, but the intensity of prevalence varies widely around the world. According to the World Health Organization (WHO), about 2 billion people worldwide have been infected with HBV, 350 million of whom are chronically infected with HBV, each year about 1 million die of liver failure due to HBV infection, liver cirrhosis and primary Hepatocellular carcinoma (HHC) [1]. Currently, there is no cure for hepatitis B (hepatitis B) in the world. Hepatitis B vaccination is the most effective way to prevent HBV infection. But inoculated with hepatitis B